FDA Hits API Manufacturer for Contamination Risks

Drug Industry Daily
A A
The FDA handed BASF a Form 483 after finding that the drugmaker’s Quincy, Florida, facility put its API products at risk of contamination and failed to follow procedures for OOS results.

To View This Article:

Login

Subscribe To Drug Industry Daily